What we promise?
Product | Atorvastatin EP Impurity I |
---|---|
CAT No. | CS-O-07293 |
CAS No. | 125971-95-1 |
Status | Available for Dispatch by 24-Sep-2023 |
Category | Impurities, Carboxylic acids and derivatives |
Mol. Wt. | 654.81 mol/g |
Mol. For. | C₄₀H₄₇FN₂O₅ |
Hazardous |
![]() |
Atorvastatin EP Impurity I is a chemical compound that is used as a reference standard for the identification and quantification of impurities in Atorvastatin, a commonly prescribed medication for the treatment of high cholesterol. Atorvastatin EP Impurity I is also known as N-(2,2-dimethyl-1-oxopropoxy)-3,5-dihydroxybenzamide and has a molecular formula of C13H17NO5. The chemical structure of Atorvastatin EP Impurity I is composed of a benzamide moiety substituted with hydroxyl and carboxyl groups. This impurity is one of the major by-products formed during the synthesis of Atorvastatin and its identification is important to ensure the purity of the final drug product. Atorvastatin EP Impurity I is typically used in analytical laboratories to develop and validate analytical methods for the determination of impurities in Atorvastatin. It can also be used as a reference standard for the purification and isolation of impurities in Atorvastatin. The chemical properties of Atorvastatin EP Impurity I are well documented in the scientific literature. It has a melting point range of 160-165°C and is sparingly soluble in water. Atorvastatin EP Impurity I is stable under normal storage conditions and does not pose any significant health or safety hazards.
Packing | Product will be supplied in Vials, in certain conditions we also use 'Septa Vials' |
---|---|
Controlled | No |
Parent API | Atorvastatin |
Purity | Not less than 90% |
Therapeutic | Anti-Diabetic |
Smileys | O=C(C(C(C1=CC=CC=C1)=C(C2=CC=C(F)C=C2)N3CC[C@@H](OC(C)(C)O4)C[C@@H]4CC(OC(C)(C)C)=O)=C3C(C)C)NC5=CC=CC=C5 |
Hazardous | Yes |
General Information | Use proper personal protective equipment |
---|---|
Handling | Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation. |
Engineering Control | Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits. Use process enclosure, local exhaust ventilation, or other engineering controls to control airborne levels. |
Clothing | Wear appropriate protective clothing to minimize contact with skin. |
Skin | Wear appropriate protective gloves and clothing to prevent skin exposure. |
Eyes | Wear safety glasses and chemical goggles if splashing is possible. |
Inhalation | Remove from exposure and move to fresh air immediately. |
![]() |
Atorvastatin EP Impu... | www.clearsynth.com |
CAT : CS-O-07293 | BATCH : CSC-WWW0757 |
|
MF: C₄₀H₄₇FN₂O₅ CAS: 125971-95-1 Date of Anaysis: 19-Aug-2023 Retest Date: 19-Jun-2026 |
MW: 654.81
Store at refrigerator (2-8C) |
Qty: 60 MG |
Only for R & D and Analytical purpose, Not for Human Consumption. |
Impurities
Impurities
API Standards
API Standards
Impurities
Impurities
Impurities
Impurities
Intermediates
Metabolites
Impurities
Impurities
Impurities
Glucuronides
Impurities
Impurities
API Standards
EP Standards
API Standards
Secondary Standards
Impurities
Impurities
Impurities
Stable Isotopes
Stable Isotopes
Stable Isotopes
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Impurities
Need a Quote?
Your email address will not be published. Required fields are marked *